Summary
This narrative review synthesises evidence on the anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids (EPA and DHA) from marine sources, contrasting their antagonistic role with pro-inflammatory omega-6 fatty acids. The authors examine molecular pathways by which omega-3 supplementation may reduce circulating inflammatory cytokines (IL-6, TNF-α) and C-reactive protein, with particular focus on cardiovascular disease, obesity, and metabolic conditions. The review identifies knowledge gaps regarding optimal dosage and duration of supplementation, noting that evidence-based dietary intake recommendations remain under-developed.
Regional applicability
The review does not specify a particular geographic context and synthesises international evidence. Its conclusions on omega-3 mechanisms and inflammatory pathways are broadly applicable to United Kingdom nutrition policy and clinical practice, though the authors note uncertainty around evidence-based dosing recommendations relevant to UK dietary guidelines.
Key measures
Inflammatory markers (IL-6, TNF-α, C-reactive protein, adiponectin); cardiovascular outcomes; disease incidence in both diseased and healthy populations
Outcomes reported
The review examines the anti-inflammatory roles of omega-3 polyunsaturated fatty acids from fish oil and their mechanisms in reducing inflammatory markers and associated disease risks. It synthesises evidence on omega-3 effects across cardiovascular disease, cancer, diabetes, obesity and other inflammatory conditions.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.